Copyright
©The Author(s) 2019.
World J Gastroenterol. Dec 21, 2019; 25(47): 6813-6822
Published online Dec 21, 2019. doi: 10.3748/wjg.v25.i47.6813
Published online Dec 21, 2019. doi: 10.3748/wjg.v25.i47.6813
Normal control, n = 30 (%) | Ulcerative colitis1, n = 30 (%) | |
Age in yr | ||
A2 (18-40) | 16 (53.3) | 17 (56.7) |
A3 (≥ 40) | 14 (46.7) | 13 (43.3) |
Sex | ||
Male | 15 (50.0) | 14 (46.7) |
Female | 15 (50.0) | 16 (53.3) |
Tissue sampling site | ||
Transverse colon | 2 (6.7) | 3 (10.0) |
Descending colon | 7 (23.3) | 6 (20.0) |
Sigmoid colon | 13 (43.3) | 9 (30.0) |
Rectum | 8 (26.7) | 12 (40.0) |
Therapy | ||
5-ASA | N/A | 13 (43.4) |
Corticosteroids | N/A | 4 (13.3) |
5-ASA/corticosteroids | N/A | 3 (10.0) |
Immunomodulators/corticosteroids | N/A | 1 (3.3) |
Chinese herbal medicine | N/A | 5 (16.7) |
No treatment | N/A | 4 (13.3) |
- Citation: Yuan CW, Sun XL, Qiao LC, Xu HX, Zhu P, Chen HJ, Yang BL. Non-SMC condensin I complex subunit D2 and non-SMC condensin II complex subunit D3 induces inflammation via the IKK/NF-κB pathway in ulcerative colitis. World J Gastroenterol 2019; 25(47): 6813-6822
- URL: https://www.wjgnet.com/1007-9327/full/v25/i47/6813.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i47.6813